Last $19.03 USD
Change Today +0.01 / 0.05%
Volume 836.1K
As of 8:10 PM 02/27/15 All times are local (Market data is delayed by at least 15 minutes).

bruker corp (BRKR) Snapshot

Open
$19.18
Previous Close
$19.02
Day High
$19.27
Day Low
$18.97
52 Week High
06/19/14 - $24.93
52 Week Low
11/7/14 - $17.26
Market Cap
3.2B
Average Volume 10 Days
1.2M
EPS TTM
$0.50
Shares Outstanding
168.6M
EX-Date
--
P/E TM
38.4x
Dividend
--
Dividend Yield
--
Current Stock Chart for BRUKER CORP (BRKR)

bruker corp (BRKR) Related Bloomberg News

View More Bloomberg News

bruker corp (BRKR) Related Businessweek News

No Related Businessweek News Found

bruker corp (BRKR) Details

Bruker Corporation, together with its subsidiaries, designs, manufactures, sells, and services proprietary life science and materials research systems, and associated products worldwide. It operates through two segments, Scientific Instruments, and Energy & Supercon Technologies. The Scientific Instruments segment offers instrumentation and automated solutions based on magnetic resonance, mass spectrometry, gas chromatography, X-ray, spark-optical emission spectroscopy, atomic force microscopy, stylus and optical metrology, and infrared and Raman molecular spectroscopy technologies. This segment serves pharmaceutical, biotechnology, and molecular diagnostic companies; academic institutions, medical schools, and other non-profit organizations; clinical microbiology laboratories; government departments and agencies; nanotechnology, semiconductor, chemical, cement, metals, and petroleum companies; and food, beverage, and agricultural analysis companies and laboratories. The Energy & Supercon Technologies segment provides superconducting materials, such as metallic low temperature superconductors for use in magnetic resonance imaging, nuclear magnetic resonance, fusion energy research, and other applications; and ceramic high temperature superconductors primarily for energy grid and magnet applications. Its customers include companies in the medical industry; private and public research and development laboratories in the fields of fundamental and applied sciences, and energy research; academic institutions; and government agencies. This segment also develops superconductors and superconducting-enabled devices for power and energy applications, as well as for industrial processing industries. The company markets its products through direct sales force; and distributors, independent sales representatives, and other representatives. Bruker Corporation was founded in 1991 and is headquartered in Billerica, Massachusetts.

bruker corp (BRKR) Top Compensated Officers

Chairman, Chief Executive Officer and Preside...
Total Annual Compensation: $547.6K
Chief Financial Officer and Executive Vice Pr...
Total Annual Compensation: $490.6K
President of Bruker Calid Group
Total Annual Compensation: $504.7K
President of Bruker of Nano Inc and Bruker Ma...
Total Annual Compensation: $430.0K
Senior Vice President of Corporate Finance an...
Total Annual Compensation: $256.5K
Compensation as of Fiscal Year 2013.

bruker corp (BRKR) Key Developments

Bruker Corporation Reports Unaudited Consolidated Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2014; Announces Impairment of Assets for the Fourth Quarter Ended December 31, 2014

Bruker Corporation reported unaudited consolidated earnings results for the fourth quarter and full year ended December 31, 2014. For the quarter, the company reported non-GAAP net income of $63.7 million or $0.30 per share, on revenue of $508 million. In the same period last year, the company reported non-GAAP net income of $81.3 million or $0.31 per share, on revenue of $552.1 million. On a GAAP basis, operating income was $44.5 million or $0.15 per share, compared with the prior-year quarter's $61 million or $0.21 per share. Non-GAAP operating income was $63.7 million compared to $81.3 million a year ago. Income before income taxes and non-controlling interest in consolidated subsidiaries was $43.5 million compared to $53.8 million a year ago. Net income attributable to the company was $26.1 million or $0.15 per diluted share compared to $35.2 million or $0.21 per diluted share a year ago. Net cash provided by operating activities was $69.3 million compared to $131.4 million a year ago. Purchases of property, plant and equipment was $7.1 million compared to $9.0 million a year ago. Non-GAAP profit before tax was $63.4 million compared to $74.1 million a year ago. For the full year, the company reported revenues of $1,808.9 million compared to $1,839.4 million a year ago. Operating income was $105.4 million compared to $148.2 million a year ago. Non-GAAP operating income was $184.4 million compared to $205.5 million a year ago. Income before income taxes and non-controlling interest in consolidated subsidiaries was $101.3 million compared to $124.6 million a year ago. Net income attributable to the company was $56.7 million or $0.33 per diluted share compared to $80.1 million or $0.48 per diluted share a year ago. Net cash provided by operating activities was $114.3 million compared to $145.0 million a year ago. Purchases of property, plant and equipment was $33.8 million compared to $50.3 million a year ago. Non-GAAP profit before tax was $174.4 million compared to $179.5 million a year ago. Non-GAAP net income attributable to the company was $127.7 million or $0.75 per diluted share compared to $129.3 million or $0.77 per diluted share a year ago. The company announced impairment of assets of $4.6 million for the fourth quarter ended December 31, 2014.

Virginia Tech Selects Two Fluorescence Microscope Solutions from Bruker Corporation

Bruker Corporation announced that the Virginia Tech Carilion Research Institute has purchased both an Opterra Multipoint Scanning Confocal Microscope and a Vutara 350 Super Resolution Microscope to research on cardiac function. The Opterra utilizes a number of innovative features to obtain the speed of wide-field imaging and the resolution of traditional confocal systems while minimizing phototoxicity, making it an ideal solution for gentle and fast confocal imaging of live-cell preparations. The Vutara 350 can break the optical diffraction limit by an order of magnitude, opening up a myriad of research opportunities in single-molecule cellular processes.

Thomas Bachmann Resigns as an Executive Officer of Bruker Corporation, Effective July 2015

On January 30, 2015, Mr. Thomas Bachmann, an executive officer of Bruker Corporation and President of the Bruker BioSpin Group since August 2013, submitted his resignation, effective as of July 2015, in order to pursue other interests. Mr. Bachmann has accepted a position as president and CEO of the Eppendorf Group, and will commence service in that position no later than August 1, 2015. Mr. Bachmann has been a member of the supervisory board of Eppendorf AG since 2013.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
BRKR:US $19.03 USD +0.01

BRKR Competitors

Market data is delayed at least 15 minutes.

Company Last Change
FEI Co $78.99 USD -0.83
National Instruments Corp $31.14 USD -0.04
Shimadzu Corp ¥1,292 JPY +19.00
Teledyne Technologies Inc $100.83 USD -0.30
Teradyne Inc $19.32 USD -0.32
View Industry Companies
 

Industry Analysis

BRKR

Industry Average

Valuation BRKR Industry Range
Price/Earnings 56.9x
Price/Sales 1.8x
Price/Book 4.1x
Price/Cash Flow 56.5x
TEV/Sales 1.3x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BRUKER CORP, please visit www.bruker.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.